---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-22-001209"
form_type: "8-K"
ticker: "CPMV"
cik: "0000836564"
company_name: "Mosaic ImmunoEngineering Inc."
filed_at: "2022-02-22T23:59:59+00:00"
generated_at: "2026-06-27T06:23:52.519826+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Mosaic ImmunoEngineering raises $342K via 8% convertible notes with board participation

## Summary
- Issued $342,632 principal of 8% convertible notes to 16 accredited investors; 5 board members invested $155,000 combined.
- Proceeds of $341,632 for general purposes; notes have no maturity, 8% simple interest, convertible in future equity financing.
- Conversion price: lesser of 80% of lowest per-share price in Qualified Financing (≥$5M) or $1.00; also convertible in smaller financings.
- Upon corporate transaction, holders may elect 1.5x principal plus interest or conversion at $1.00 per share.
- Amended May 2021 notes for certain purchasers: conversion price replaced with same formula (80% discount or $1.00).

## SEC filing metadata
- accession: 0001683168-22-001209
- form_type: 8-K
- ticker: CPMV
- cik: 0000836564
- company_name: Mosaic ImmunoEngineering Inc.
- filed_at: 2022-02-22T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/836564/000168316822001209/0001683168-22-001209-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/836564/000168316822001209/mosiac_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-22-001209
- JSON: https://secwatch.observer/filing/0001683168-22-001209.json
- Plain text: https://secwatch.observer/filing/0001683168-22-001209.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.